Profit Statement | 2019 | 2020 | 2021 | |
Sales | CZK mil | 5,623 | 5,828 | 5,720 |
Gross Profit | CZK mil | 831 | 762 | 799 |
EBITDA | CZK mil | 146 | 88.8 | 185 |
EBIT | CZK mil | -24.3 | -28.6 | 115 |
Financing Cost | CZK mil | 14.6 | 4.43 | 0 |
Pre-Tax Profit | CZK mil | -40.5 | -35.6 | 111 |
Net Profit | CZK mil | -41.5 | -27.8 | 86.7 |
Balance Sheet | 2019 | 2020 | 2021 | |
Total Assets | CZK mil | 2,230 | 2,209 | 1,964 |
Non-Current Assets | CZK mil | 334 | 266 | 202 |
Current Assets | CZK mil | 1,843 | 1,892 | 1,698 |
Working Capital | CZK mil | 661 | -19.4 | 107 |
Shareholders' Equity | CZK mil | 19.5 | 1.31 | 88.0 |
Liabilities | CZK mil | 2,211 | 2,207 | 1,876 |
Total Debt | CZK mil | 698 | 0.597 | 0.483 |
Net Debt | CZK mil | 664 | -45.7 | -34.4 |
Ratios | 2019 | 2020 | 2021 | |
ROE | % | -90.7 | -266 | 194 |
ROCE | % | -4.96 | -4.47 | 31.2 |
Gross Margin | % | 14.8 | 13.1 | 14.0 |
EBITDA Margin | % | 2.60 | 1.52 | 3.24 |
EBIT Margin | % | -0.433 | -0.492 | 2.00 |
Net Margin | % | -0.739 | -0.476 | 1.51 |
Net Debt/EBITDA | 4.54 | -0.515 | -0.186 | |
Net Debt/Equity | % | 3,396 | -3,500 | -39.1 |
Cost of Financing | % | 2.37 | 1.27 | 0 |
Cash Flow | 2019 | 2020 | 2021 | |
Total Cash From Operations | CZK mil | -121 | 42.0 | -6.87 |
Total Cash From Investing | CZK mil | -61.1 | -39.4 | -4.42 |
Total Cash From Financing | CZK mil | 162 | 9.59 | -0.114 |
Net Change In Cash | CZK mil | -19.6 | 12.2 | -11.4 |
Cash Conversion Cycle | days | 47.4 | -3.92 | 5.94 |
Cash Earnings | CZK mil | 129 | 89.6 | 157 |
Free Cash Flow | CZK mil | -182 | 2.62 | -11.3 |
Get all company financials in excel:
overview | Unit | 2018 | 2019 | 2020 | 2021 |
income statement | |||||
Sales | CZK mil | 5,525 | 5,623 | ||
Gross Profit | CZK mil | 820 | 831 | ||
EBIT | CZK mil | -3.54 | -24.3 | ||
Net Profit | CZK mil | -11.8 | -41.5 | ||
ROE | % | ... | -90.7 | ||
EBIT Margin | % | -0.064 | -0.433 | ||
Net Margin | % | -0.214 | -0.739 | ||
Employees | 2,384 | 2,415 | |||
balance sheet | |||||
Total Assets | CZK mil | 2,443 | 2,230 | ||
Non-Current Assets | CZK mil | 433 | 334 | ||
Current Assets | CZK mil | 1,810 | 1,843 | ||
Shareholders' Equity | CZK mil | 72.1 | 19.5 | ||
Liabilities | CZK mil | 2,371 | 2,211 | ||
Non-Current Liabilities | CZK mil | 1.61 | 0.534 | ||
Current Liabilities | CZK mil | 2,253 | 2,079 | ||
Net Debt/EBITDA | 2.27 | 4.54 | |||
Net Debt/Equity | % | 669 | 3,396 | ||
Cost of Financing | % | ... | 2.37 | ||
cash flow | |||||
Total Cash From Operations | CZK mil | 242 | -121 | ||
Total Cash From Investing | CZK mil | -88.8 | -61.1 | ||
Total Cash From Financing | CZK mil | -146 | 162 | ||
Net Change In Cash | CZK mil | 7.90 | -19.6 |
income statement | Unit | 2018 | 2019 | 2020 | 2021 |
income statement | |||||
Sales | CZK mil | 5,525 | 5,623 | ||
Cost of Goods & Services | CZK mil | 4,705 | 4,792 | ||
Gross Profit | CZK mil | 820 | 831 | ||
Staff Cost | CZK mil | 804 | 844 | ||
Other Operating Cost (Income) | CZK mil | -200 | -184 | ||
EBITDA | CZK mil | 212 | 146 | ||
Depreciation | CZK mil | 216 | 171 | ||
EBIT | CZK mil | -3.54 | -24.3 | ||
Net Financing Cost | CZK mil | 9.84 | 16.2 | ||
Financing Cost | CZK mil | 8.95 | 14.6 | ||
Financing Income | CZK mil | 1.47 | 0.981 | ||
Extraordinary Cost | CZK mil | 0 | 0 | ||
Pre-Tax Profit | CZK mil | -13.4 | -40.5 | ||
Tax | CZK mil | -1.56 | 1.02 | ||
Minorities | CZK mil | 0 | 0 | ||
Net Profit | CZK mil | -11.8 | -41.5 | ||
Net Profit Avail. to Common | CZK mil | -11.8 | -41.5 | ||
growth rates | |||||
Total Revenue Growth | % | ... | 1.76 | ||
Staff Cost Growth | % | ... | 4.96 | ||
EBITDA Growth | % | ... | -31.2 | ||
EBIT Growth | % | ... | 587 | ||
Pre-Tax Profit Growth | % | ... | 203 | ||
Net Profit Growth | % | ... | 252 | ||
ratios | |||||
ROE | % | ... | -90.7 | ||
ROA | % | ... | -1.78 | ||
ROCE | % | ... | -4.96 | ||
Gross Margin | % | 14.8 | 14.8 | ||
EBITDA Margin | % | 3.85 | 2.60 | ||
EBIT Margin | % | -0.064 | -0.433 | ||
Net Margin | % | -0.214 | -0.739 | ||
Cost of Financing | % | ... | 2.37 | ||
Net Debt/EBITDA | 2.27 | 4.54 |
balance sheet | Unit | 2018 | 2019 | 2020 | 2021 |
balance sheet | |||||
Cash & Cash Equivalents | CZK mil | 53.7 | 34.1 | ||
Receivables | CZK mil | 241 | 268 | ||
Inventories | CZK mil | 1,515 | 1,540 | ||
Current Assets | CZK mil | 1,810 | 1,843 | ||
Property, Plant & Equipment | CZK mil | 433 | 334 | ||
LT Investments & Receivables | CZK mil | 0 | 0 | ||
Intangible Assets | CZK mil | 0.054 | 0.011 | ||
Goodwill | CZK mil | 0 | 0 | ||
Non-Current Assets | CZK mil | 433 | 334 | ||
Total Assets | CZK mil | 2,443 | 2,230 | ||
Trade Payables | CZK mil | 1,509 | 1,147 | ||
Short-Term Debt | CZK mil | 534 | 697 | ||
Other ST Liabilities | CZK mil | 209 | 234 | ||
Current Liabilities | CZK mil | 2,253 | 2,079 | ||
Long-Term Debt | CZK mil | 1.61 | 0.534 | ||
Other LT Liabilities | CZK mil | 0 | 0 | ||
Non-Current Liabilities | CZK mil | 1.61 | 0.534 | ||
Liabilities | CZK mil | 2,371 | 2,211 | ||
Equity Before Minority Interest | CZK mil | 72.1 | 19.5 | ||
Minority Interest | CZK mil | 0 | 0 | ||
Equity | CZK mil | 72.1 | 19.5 | ||
growth rates | |||||
Total Asset Growth | % | ... | -8.71 | ||
Shareholders' Equity Growth | % | ... | -72.9 | ||
Net Debt Growth | % | ... | 37.6 | ||
Total Debt Growth | % | ... | 30.2 | ||
ratios | |||||
Total Debt | CZK mil | 536 | 698 | ||
Net Debt | CZK mil | 482 | 664 | ||
Working Capital | CZK mil | 247 | 661 | ||
Capital Employed | CZK mil | 680 | 996 | ||
Net Debt/Equity | % | 669 | 3,396 | ||
Current Ratio | 0.804 | 0.886 | |||
Quick Ratio | 0.131 | 0.145 |
cash flow | Unit | 2018 | 2019 | 2020 | 2021 |
cash flow | |||||
Net Profit | CZK mil | -11.8 | -41.5 | ||
Depreciation | CZK mil | 216 | 171 | ||
Non-Cash Items | CZK mil | ... | 164 | ||
Change in Working Capital | CZK mil | ... | -414 | ||
Total Cash From Operations | CZK mil | 242 | -121 | ||
Capital Expenditures | CZK mil | -93.2 | -70.7 | ||
Other Investing Activities | CZK mil | 4.35 | 9.58 | ||
Total Cash From Investing | CZK mil | -88.8 | -61.1 | ||
Dividends Paid | CZK mil | 0 | 0 | ||
Issuance Of Shares | CZK mil | 0 | 0 | ||
Issuance Of Debt | CZK mil | -146 | 162 | ||
Total Cash From Financing | CZK mil | -146 | 162 | ||
Net Change In Cash | CZK mil | 7.90 | -19.6 | ||
ratios | |||||
Days Sales Outstanding | days | 15.9 | 17.4 | ||
Days Sales Of Inventory | days | 118 | 117 | ||
Days Payable Outstanding | days | 117 | 87.4 | ||
Cash Conversion Cycle | days | 16.4 | 47.4 | ||
Cash Earnings | CZK mil | 204 | 129 | ||
Free Cash Flow | CZK mil | 154 | -182 | ||
Capital Expenditures (As % of Sales) | % | 1.69 | 1.26 |
other ratios | Unit | 2018 | 2019 | 2020 | 2021 |
Employees | 2,384 | 2,415 | |||
Cost Per Employee | USD per month | 1,285 | 1,292 | ||
Cost Per Employee (Local Currency) | CZK per month | 28,119 | 29,134 | ||
Material & Energy (As % of Sales) | % | 70.0 | 69.9 | ||
Services (As % of Sales) | % | 15.2 | 15.4 | ||
Staff Cost (As % of Sales) | % | 14.6 | 15.0 | ||
Effective Tax Rate | % | 11.7 | -2.51 |
Get all company financials in excel:
Teta Drogerie a Lekarny has been growing its sales by a year on average in the last 5 years. EBITDA has grown by 0% during that time to total of CZK 185 mil in 2021, or 3.24% of sales. That’s compared to 2.80% average margin seen in last five years.
The company netted CZK 86.7 mil in 2021 implying ROE of 194% and ROCE of 31.2%. Again, the average figures were -54.3% and 7.26%, respectively when looking at the previous 5 years.
Teta Drogerie a Lekarny’s net debt amounted to CZK -34.4 mil at the end of 2021, or -39.1% of equity. When compared to EBITDA, net debt was -0.186x, down when compared to average of 1.53x seen in the last 5 years.